SCHEMBL14840893

SCHEMBL14840893

FC(F)(F)c1ccc2oc(-c3ccncc3Cl)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.42
PIM2 Q9P1W9 2/20 0.42
KIF11 P52732 2/20 0.39
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
FFAR1 O14842 1/20 0.36
LATS1 O95835 2/20 0.36
MAOB P27338 1/20 0.36
PDE4D Q08499 1/20 0.36
JUN P05412 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
LATS2 Q9NRM7 1/20 0.36
PDE2A O00408 2/20 0.35
PDE10A Q9Y233 2/20 0.35
CHUK O15111 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14840456 0.85 PIM1 (0.43) PIM1PIM2KIF11FFAR1LATS1
SCHEMBL14840290 0.81 PIM1 (0.39) PIM1PIM2KIF11FFAR1MAOB
SCHEMBL14840861 0.81 CYP1A2 (0.46) PIM1PIM2MAOBPDE2APDE10A
SCHEMBL12071096 0.81 PIM1 (0.42) PIM1PIM2FFAR1MAOBPDE2A
SCHEMBL14848964 0.80 MAOB (0.50) MAOBPDE4DNPC1ALDH1A1RAB9A
SCHEMBL14841414 0.78 PIM1 (0.37) PIM1PIM2KIF11FFAR1MAOB
SCHEMBL1026561 0.78 AGPAT2 (0.52) KIF11CNR2NPC1ALDH1A1MAPT
SCHEMBL10901776 0.77 FFAR1 (0.52) PIM1PIM2KIF11FFAR1MAOB
SCHEMBL14840752 0.77 PIM1 (0.36) PIM1PIM2FFAR1MAOAJAK2
SCHEMBL27914907 0.77 PIM1 (0.38) PIM1PIM2FFAR1MAOBPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796306-B2 Noxious arthropod controlling composition and heterocyclic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-08-05 US disclosed
US-8796306-B2 Noxious arthropod controlling composition and heterocyclic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-08-05 US disclosed
US-20130090353-A1 NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-11 US disclosed
US-20130090353-A1 NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-11 US disclosed
CN-103037694-A Harmful arthropod-controlling composition and heterocyclic compound SUMITOMO CHEMICAL CO 2013-04-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090353-A1 NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND C5, C3AR1, TRPA1 PIM1 4830/4885PIM2 4859/4885KIF11 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.